Atossa Therapeutics, Inc.
Pharmaceutical Preparations · Seattle, WA, United States
- PrincipalsMark James DanielChief Financial OfficerSteven C QuayPresident & CEO
- CompanyAtossa Therapeutics, Inc.Seattle, WA, United States
- Phone line+1 (206) 588-0256General business
Atossa Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ATOS) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 2
Chief executive
Steven C QuayPresident & CEO
Finance
Mark James DanielChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Steven C Quay — President & CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Mark James Daniel — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Teva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capability